14 August 2013 -- The BioIndustry Association (BIA) is pleased to highlight the fact that more financial assistance than ever before is available to eligible organisations who wish to join international trade missions to biotech events this autumn.
As a Government Accredited Trade Organisation the BIA works closely with BioPartner UK and UK Trade and Investment (UKTI) to offer members the opportunity to join supported UK delegations to major biotech conferences around the globe. Grant funding is available to eligible BIA and BioPartner member companies to significantly offset costs for many of the missions, with discounts also available on some flights.

Attending an international trade delegation, either as an exhibitor or simply a conference attendee, gives companies and research or academic institutions the chance to save money while raising their profile at the conference. The UK Pavilion can be used as a base to display literature and organisation logos whilst delegates attend partnering meetings and presentations. Other benefits of joining the UK delegation include organisational assistance and on-site support such as SMS notification of networking opportunities.

Steve Bates, BIA Chief Executive Officer, said:

"We always hear fantastic feedback from companies who have joined a UK delegation to international biotech events. Joining the UK Pavilion really increases a company's presence and, together with the financial assistance offered to members through our close relationship with BioPartner UK and UKTI, these trade missions open up excellent networking opportunities to organisations of any size."

Details of trade missions organised by the BIA and BioPartner UK are available via

http://www.bioindustry.org/events/international-missions-and-events/

BioIndustry Association

Founded over 20 years ago at the infancy of biotechnology, the BioIndustry Association (BIA) is the trade association for innovative enterprises involved in UK bioscience. Members include emerging and more established bioscience companies; pharmaceutical companies; academic, research and philanthropic organisations; and service providers to the bioscience sector. The BIA represents the interests of its members to a broad section of stakeholders, from government and regulators to patient groups and the media. Our goal is to secure the UK's position as a global hub and as the best location for innovative research and commercialisation, enabling our world-leading research base to deliver healthcare solutions that can truly make a difference to people's lives. For further information, please go to www.bioindustry.org